| Ticker Details |
Biogen Inc.
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$28.61B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.41 | 1.33%
|
| Avg Daily Range (30 D): |
$2.78 | 1.48%
|
| Avg Daily Range (90 D): |
$2.87 | 1.55%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.05M |
| Avg Daily Volume (30 D): |
.92M |
| Avg Daily Volume (90 D): |
.96M |
| Trade Size |
| Avg Trade Size (Sh.): |
104 |
| Avg Trade Size (Sh.) (30 D): |
39 |
| Avg Trade Size (Sh.) (90 D): |
38 |
| Institutional Trades |
| Total Institutional Trades: |
44,916 |
| Avg Institutional Trade: |
$6.21M |
| Avg Institutional Trade (30 D): |
$16M |
| Avg Institutional Trade (90 D): |
$15.04M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
7 |
| Market Closing Trades |
| Avg Closing Trade: |
$28.55M |
| Avg Closing Trade (30 D): |
$39.93M |
| Avg Closing Trade (90 D): |
$42.92M |
| Avg Closing Volume: |
139.67K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$9.35
|
$2.17
|
$-.33
|
|
Diluted EPS
|
$9.3
|
$2.15
|
$-.35
|
|
Revenue
|
$9.94B
|
$2.48B
|
$2.28B
|
|
Gross Profit
|
$7.5B
|
$1.82B
|
$1.78B
|
|
Net Income / Loss
|
$1.37B
|
$319.5M
|
$-48.9M
|
|
Operating Income / Loss
|
$1.62B
|
$377.7M
|
$-56M
|
|
Cost of Revenue
|
$2.44B
|
$661M
|
$495.5M
|
|
Net Cash Flow
|
$784.4M
|
$374.2M
|
$-854.3M
|
|
PE Ratio
|
|
|
|
|
|
|
